|
US2009215791A1
|
|
New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d]pyrimidine
|
|
WO2008153884A1
|
|
Compositions useful for treating gastroesophageal reflux disease
|
|
US2008269276A1
|
|
Compositions useful for treating irritable bowel syndrome
|
|
AU2007202664A1
|
|
4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-D) pyrimidine in the treatment of functional bowel disorder
|
|
US2007254899A1
|
|
Soluble salts of thieno[2,3-d]pyrimidine derivatives
|
|
AU2007309718A1
|
|
Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno(2,3-d)pyrimidine
|
|
AU2007200317A1
|
|
Method of treating lower urinary tract disorders
|
|
US2007010543A1
|
|
Compositions and methods for treating gastrointestinal hypomotility and associated disorders
|
|
WO2006105117A2
|
|
Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
|
|
WO2005117872A2
|
|
Dual acting snri-nmda antagonists for the treatment of genitourinary disorders
|
|
AU2005200045A1
|
|
Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine for the treatment of pain
|
|
US2005148587A1
|
|
Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders
|
|
US2005113421A1
|
|
Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating non-inflammatory gastrointestinal tract disorders
|
|
CA2537182A1
|
|
Compositions useful for treating gastrointestinal motility disorders
|
|
CN1874773A
|
|
Compositions useful for treating gastrointestinal motility disorders
|
|
US2005026835A1
|
|
Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators
|
|
US2004248979A1
|
|
Method of treating lower urinary tract disorders
|
|
CA2519379A1
|
|
Method of treating lower urinary tract disorders
|
|
EP1795196A2
|
|
Method of treating lower urinary tract disorders
|
|
ZA200507879B
|
|
Methods for treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators
|
